Form 4: Sabra Health Care CFO Receives Dividend Equivalent Stock Units
Insider Transaction Report
Sabra Health Care REIT's Executive VP, CFO & Secretary, Michael Lourenco Costa, was credited with 3,473 stock units as dividend equivalent payments.
Summary
- Michael Lourenco Costa, Executive VP, CFO & Secretary of Sabra Health Care REIT, Inc. (SBRA), was credited with 3,473 common stock units on August 29, 2025.
- These units represent dividend equivalent payments on previously granted stock units under the Issuer's 2009 Performance Incentive Plan.
- The units were calculated based on the market value of the Issuer's common stock on the dividend payment date and will vest and become payable under the same terms as the original stock units.
- Following this transaction, Costa directly beneficially owns 351,822 common stock units, which includes 224,780 stock units payable one-for-one in shares upon settlement.
- Additionally, Costa indirectly owns 784 common stock units via his IRA and 207 common stock units via his spouse's IRA.
Sentiment
Score: 7
Explanation: The transaction is a routine, positive event for the executive, reflecting ongoing compensation and alignment of interests. It's not a major market-moving event but indicates stability in executive compensation practices.
Positives
- Increased beneficial ownership for a key executive, Michael Lourenco Costa, aligning management interests with shareholders.
- The transaction is a non-cash dividend equivalent, indicating a routine and ongoing retention mechanism for executive compensation.
Future Outlook
NA
Industry Context
This is a routine insider transaction related to executive compensation in the REIT sector. It reflects standard practices for aligning executive incentives with shareholder returns through equity-based compensation and dividend equivalents, common across publicly traded companies.
Comparison to Industry Standards
- The practice of granting dividend equivalents on unvested stock units is a common compensation mechanism in the REIT industry and broader corporate landscape, aiming to provide executives with the full economic benefit of their equity awards, including dividends, before the shares fully vest.
- Many publicly traded companies, including other healthcare REITs like Ventas (VTR) or Welltower (WELL), utilize similar equity incentive plans that include dividend equivalent rights to retain and incentivize key management personnel.
Stakeholder Impact
- Shareholders: The transaction aligns the interests of a key executive with shareholders by increasing his equity stake, potentially encouraging long-term value creation.
- Employees: Reflects the company's ongoing executive compensation structure and commitment to equity-based incentives.
Next Steps
- The credited stock units will vest and become payable on the same terms as the original stock units to which they relate.
Key Dates
| Date | Description |
|---|---|
| 08/29/2025 | Date of transaction where stock units were acquired as dividend equivalents. |
| 09/03/2025 | Date the Form 4 was signed and filed by the reporting person. |
Recommendation
holdThis Form 4 filing details a routine executive compensation event (dividend equivalent stock units) and does not provide new information that would fundamentally alter the investment thesis for Sabra Health Care REIT. It reinforces management's alignment with shareholder interests but does not present a catalyst for a 'buy' or 'sell' recommendation. Therefore, a 'hold' recommendation is appropriate based solely on this filing.
Keywords
Sabra Health Care REIT, SBRA, Michael Lourenco Costa, Form 4, Insider Transaction, Stock Units, Dividend Equivalent, Executive Compensation, REIT
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.